BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3970704)

  • 1. Development of transformed phenotype induced by a human ras oncogene is inhibited by interferon.
    Samid D; Chang EH; Friedman RM
    Biochem Biophys Res Commun; 1985 Jan; 126(1):509-16. PubMed ID: 3970704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of viral and somatic activations of the cHa-ras gene.
    Tabin CJ; Weinberg RA
    J Virol; 1985 Jan; 53(1):260-5. PubMed ID: 2981345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of interferon on the genetic and oncogenic transformation by viral and cellular genes.
    Perucho M; Esteban M
    J Virol; 1985 Apr; 54(1):229-32. PubMed ID: 3973979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-induced modulation of human ras oncogene expression.
    Samid D; Schaff Z; Chang EH; Friedman RM
    Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ; Williams JE; Lowy DR; Liotta LA
    Am J Pathol; 1985 Oct; 121(1):1-8. PubMed ID: 3901774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harvey murine sarcoma virus: influences of coding and noncoding sequences on cell transformation in vitro and oncogenicity in vivo.
    Velu TJ; Vass WC; Lowy DR; Tambourin PE
    J Virol; 1989 Mar; 63(3):1384-92. PubMed ID: 2536840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene.
    Parada LF; Tabin CJ; Shih C; Weinberg RA
    Nature; 1982 Jun; 297(5866):474-8. PubMed ID: 6283357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to oncogenic transformation in revertant R1 of human ras-transformed NIH 3T3 cells.
    Kuzumaki N; Ogiso Y; Oda A; Fujita H; Suzuki H; Sato C; Müllauer L
    Mol Cell Biol; 1989 May; 9(5):2258-63. PubMed ID: 2664473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation by viral and cellular oncogenes of a mouse BALB/3T3 cell mutant resistant to transformation by chemical carcinogens.
    Ono M; Yakushinji M; Segawa K; Kuwano M
    Mol Cell Biol; 1988 Oct; 8(10):4190-6. PubMed ID: 3054511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.
    Samid D; Flessate DM; Friedman RM
    Mol Cell Biol; 1987 Jun; 7(6):2196-200. PubMed ID: 2439904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
    Benjamin CW; Tarpley WG; Gorman RR
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):546-50. PubMed ID: 3099298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line.
    Katz E; Carter BJ
    Cancer Res; 1986 Jun; 46(6):3023-6. PubMed ID: 3009007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.
    Sergiescu D; Gerfaux J; Joret AM; Chany C
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5764-8. PubMed ID: 3016718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.
    Tarpley WG; Hopkins NK; Gorman RR
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3703-7. PubMed ID: 3012529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH/3T3 cells transfected with Ha-MuSV DNA.
    Tagliaferri P; Clair T; DeBortoli ME; Cho-Chung YS
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1193-200. PubMed ID: 2992503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.